Mylle Pharma SRL
Mylle Pharma reported total assets of 947,525 € at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Feb 2026).
By total assets for 2025, Mylle Pharma ranks in the top half of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Mylle Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +5 % Total assets +5 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mylle Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 128,190 € | ||||
| Equity | 478,571 € | ||||
| Cash | 78,386 € | ||||
| EBITDA | 65,603 € | ||||
| Total assets | 947,525 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 06 Feb 2026
- Year ended 30 Sep 2024filed on 17 Feb 2025
- Year ended 30 Sep 2023filed on 29 Apr 2024
- Year ended 30 Sep 2022filed on 15 Mar 2023
- Year ended 30 Sep 2021filed on 16 Feb 2022
Mylle Pharma's financial analysis
- Solvency50.5%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mylle Pharma
Mylle Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0566.940.155
- VAT number
- BE0566940155
- Peppol
- Registered · 0208:0566940155 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Oct 2014
- Registered office
- 8570 Anzegem
- Latest accounts
- 2025 · filed on 06 Feb 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Mylle Pharma (SRL) has been based in Anzegem since 2014, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 128,190 € and equity of 478,571 €; its revenue is not published. Its solvency stands at 50.5%, above the median of its sector (44.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Mylle Pharma
Companies in the same business, of comparable size and area, outside its group.
- ANAP Retail sale of pharmaceutical products Aalst · balance sheet €1.37m
- Apotheek het Perron Retail sale of pharmaceutical products Poperinge · balance sheet 862,885 €
- Rozental & Herman Retail sale of pharmaceutical products Charleroi · balance sheet €1.05m
- Pharmanaus Retail sale of pharmaceutical products Herve · balance sheet €1.18m
- Thomas Broos Retail sale of pharmaceutical products Herent · balance sheet €1.19m
- Pharmacie d'Helecine Retail sale of pharmaceutical products Hélécine · balance sheet €1.22m
- Cosmephar Retail sale of pharmaceutical products Antwerp · balance sheet 561,007 €
- VRB Farma Retail sale of pharmaceutical products Mechelen · balance sheet 551,620 €
Frequently asked questions about Mylle Pharma
What is the revenue of Mylle Pharma?
Mylle Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Mylle Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0566940155 for Mylle Pharma, if the company is VAT-registered. Its company number (CBE) is 0566.940.155.
Where is the registered office of Mylle Pharma?
According to the CBE register, the registered office of Mylle Pharma is in 8570 Anzegem.
What is the equity of Mylle Pharma?
At the close of the 2025 financial year, the equity of Mylle Pharma amounts to 478,571 €, a solvency of 50.5% of total assets.
Who manages Mylle Pharma?
The register lists 1 active mandates at Mylle Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Mylle Pharma within its sector?
By total assets for 2025, Mylle Pharma ranks in the top half of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year.
The full file of Mylle Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →